Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion type Assertion NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_head.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion description "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion evidence source_evidence_literature NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion SIO_000772 24898067 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion wasDerivedFrom befree-2016 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion wasGeneratedBy ECO_0000203 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.